Semaglutide and Intermittent Fasting: A Powerful Fat Burn Combo
Integrating Pharmacological and Metabolic Strategies: The Rationale Behind Combining Semaglutide with Intermittent Fasting In the evolving landscape of obesity management, the synergistic combination of semaglutide—a glucagon-like peptide-1 (GLP-1) receptor agonist—and intermittent fasting presents a compelling paradigm for accelerated fat loss. Semaglutide’s pharmacodynamic profile, characterized by appetite suppression and enhanced glycemic control, complements intermittent fasting’s metabolic … Read more